Laura Nijstad

8PUBLICATIONS
23CO-AUTHORS
Information systems development methodologies and practiceFood properties (incl. characteristics and health benefits)Toxicology (incl. clinical toxicology)ChemotherapyPaediatrics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 12, 2026
Digitising controlled substance accountability: implementation and use of a dashboard-based monitoring system in an university hospital.

|May 05, 2026
Ketoproof? A systematic classification of pharmaceutical excipients for ketogenic diet therapy.

|Oct 26, 2022
Overestimation of the effect of (fos)aprepitant on intravenous dexamethasone pharmacokinetics requires adaptation of the guidelines for children with chemotherapy-induced nausea and vomiting.

A Laura Nijstad, Evelien de Vos-Kerkhof, Catherine F Enters-Weijnen

|Aug 19, 2022
A Population Pharmacokinetic Modelling Approach to Unravel the Complex Pharmacokinetics of Vincristine in Children.

A Laura Nijstad, Wan-Yu Chu, Evelien de Vos-Kerkhof

|Apr 04, 2022
A simple extemporaneous oral suspension of aprepitant yields sufficient pharmacokinetic exposure in children.

A Laura Nijstad, Evelien de Vos-Kerkhof, Catherine F Enters-Weijnen

|Feb 08, 2022
Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia.

Linde Dekker, Friso G Calkoen, Yilin Jiang

Pageof 2

Frequent Collaborators

2 joint publications

Alwin D R Huitema

1 joint publications

Natasha K A van Eijkelenburg

1 joint publications

Marc R Lilien

1 joint publications

Linde Dekker